கிலியட் தொடர்புகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press release content from Business Wire. The AP news staff was not involved in its creation.
Gilead Sciences and Gritstone Announce Collaboration Utilizing Gritstone’s Vaccine Platform Technology for HIV Cure
February 1, 2021 GMT
FOSTER CITY, Calif. & EMERYVILLE, Calif. (BUSINESS WIRE) Feb 1, 2021
Gilead Sciences, Inc. (Nasdaq: GILD) and Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation cancer and infectious disease immunotherapies, today announced that the companies have entered into a collaboration, option and license agreement to research and develop a vaccine-based immunotherapy as part of Gilead’s efforts to find a curative treatment for human immunodeficiency virus (HIV) infection. ....

United States , Foster City , Andrew Allen , Jacquie Ross , Dan Budwick , Karin Jooss , Alexandra Santos , Diana Brainard , Mark Snyder , Gilead Sciences , National Institutes Of Health , Gritstone Oncology Inc , Melinda Gates Foundation , Gilead Sciences Inc , Exchange Commission , Jolla Institute For Immunology , Gritstone Oncology , Senior Vice President , Virology Therapeutic Area , Chief Executive Officer , Executive Vice President , Chief Scientific Officer , National Institutes , Quarterly Report , Private Securities Litigation Reform Act , Gilead Contacts ,